enrgy: zenocutuzumab in nrg1 fusion-positive pancreatic ductal adenocarcinoma
Published 9 months ago • 97 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:29
enrgy: zenocutuzumab in nrg1 fusion–positive tumors
-
4:03
phase i/ii trial of zenocutuzumab for tumors with nrg1 fusions
-
1:12
supporting ngs for pancreatic ductal adenocarcinoma
-
1:16
entinostat with nivolumab in pancreatic ductal adenocarcinoma
-
0:54
targeting local recurrence in pancreatic adenocarcinoma with proton therapy
-
1:26
immune checkpoint inhibition for pancreatic ductal adenocarcinoma a systematic review
-
1:13
new pancreatic ductal adenocarcinoma clinical trial: rmc 6236 for pancreatic ductal adenocarcinoma
-
0:34
targeted therapy for pancreatic ductal adenocarcinoma: mechanisms and clinical study | rtcl.tv
-
1:15
proton-panc: proton therapy in adjuvant pancreatic cancer
-
59:01
treatment approaches for pancreatic adenocarcinoma
-
1:02:12
pancreatic adenocarcinoma: state-of-the-art and molecularly targeted opportunities
-
9:16
behind the mystery: nrg1 fusions
-
1:05:44
innovations in chemotherapy and surgery for ductal adenocarcinoma of the pancreas
-
2:08
philip philip, md, phd, frcp, regarding key unmet needs in pancreatic ductal adenocarcinoma
-
27:05
pancreatic cancer
-
53:11
focus on: pancreatic cancer
-
17:32
pancreatic ductal adenocarcinoma versus mass forming pancreatitis delivered by prof. wolfgang schima
-
0:39
targeting kras in pancreatic ductal adenocarcinoma: the long road to cure | rtcl.tv
-
2:13
dr. fine on gtx in inoperable pancreatic cancer